Brain parenchymal TNF-α and IL-1β induction in experimental pneumococcal meningitis

Journal of Neuroimmunology

Volumn 276, Issue 1-2, 2014, Pages 104-111

  Izadpanah, Kaywan ^a,b   Freyer, Dorette ^a   Weber, Joerg R ^a,c   Braun, Johann S ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Klinikum Klagenfurt   (Austria)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Brain; IL 1 ; Meningitis; Pneumococcal cell wall; S. pneumoniae; TNF

Indexed keywords

CYTOKINE; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE INHIBITOR; PNEUMOLYSIN; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; CD18 ANTIGEN; DIPEPTIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; MATRIX METALLOPROTEINASE; N-(2(R)-2-(HYDROXAMIDOCARBONYLMETHYL)-4-METHYLPENTANOYL)-L-TRYPTOPHAN METHYLAMIDE; PHOSPHORYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BACTERIAL CELL WALL; BRAIN TISSUE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME INDUCTION; ENZYME SYNTHESIS; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; HIPPOCAMPUS; IMMUNOPATHOGENESIS; IN SITU HYBRIDIZATION; LEUKOCYTOSIS; MALE; MOUSE; NERVE CELL; NONHUMAN; PNEUMOCOCCAL MENINGITIS; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BACTERIAL COUNT; BRAIN; C57BL MOUSE; DISEASE MODEL; DURA MATER; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MENINGITIS, PNEUMOCOCCAL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES; ANTIGENS, CD18; BRAIN; COLONY COUNT, MICROBIAL; DIPEPTIDES; DISEASE MODELS, ANIMAL; DURA MATER; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, INBRED C57BL; PHOSPHORYLCHOLINE; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908599415     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.08.625     Document Type: Article

References (41)

1. Agyeman P., Grandgirard D., Leib S.L. Pathogenesis and pathophysiology of bacterial infections. Infections of the Central Nervous System 2014, 341-364. Wolters Kluwer, Philadelphia. 4th edition. W.M. Scheld, R.J. Whitley, C.M. Marra (Eds.).
2. Barichello T., dos Santos I., Savi G.D., Simões L.R., Silvestre T., Comim C.M., Sachs D., Teixeira M.M., Teixeira A.L., Quevedo J. TNF-α, IL-1β, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae. J. Neuroimmunol. 2010, 221:42-45.
3. Bermpohl D., Halle A., Freyer D., Dagand E., Braun J.S., Bechmann I., Schröder N.W., Weber J.R. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J. Clin. Invest. 2005, 115:1607-1615.
4. Bitsch A., Trostdorf F., Brück W., Schmidt H., Fischer F.R., Nau R. Central nervous system TNFalpha-mRNA expression during rabbit experimental pneumococcal meningitis. Neurosci. Lett. 1997, 237:105-108.
5. Blewett A.M., Lloyd A.J., Echalier A., Fülöp V., Dowson C.G., Bugg T.D., Roper D.I. Expression, purification, crystallization and preliminary characterization of uridine 5'-diphospho-N-acetylmuramoyl l-alanyl-d-glutamate:lysine ligase (MurE) from Streptococcus pneumoniae 110K/70. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:359-361.
6. Böttcher T., Ren H., Goiny M., Gerber J., Lykkesfeldt J., Kuhnt U., Lotz M., Bunkowski S., Werner C., Schau I., Spreer A., Christen S., Nau R. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. J. Neurochem. 2004, 91:1450-1460.
7. Braun J.S., Novak R., Herzog K.H., Bodner S.M., Cleveland J.L., Tuomanen E.I. Neuroprotection by a caspase inhibitor in pneumococcal meningitis. Nat. Med. 1999, 5:298-302.
8. Braun J.S., Novak R., Gao G., Murray P.J., Shenep J.L. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces NO production from macrophages. Infect. Immun. 1999, 67:3750-3756.
9. Braun J.S., Novak R., Murray P.J., Eischen C.M., Susin S.A., Kroemer G., Halle A., Weber J.R., Tuomanen E.I., Cleveland J.L. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J. Infect. Dis. 2001, 184:1300-1309.
10. 2 mediate brain cell apoptosis during meningitis. J. Clin. Invest. 2002, 109:19-27.
11. Breitschopf H., Suchanek G., Gould R.M., Colman D.R., Lassmann H. In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol. 1992, 84:581-587.
12. Clausen B.H., Lambertsen K.L., Meldgaard M., Finsen B. A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 2005, 132:879-892.
13. Diab A., Zhu J., Lindquist L., Wretlind B., Bakhiet M., Link H. Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitis. Clin. Exp. Immunol. 1997, 109:233-241.
14. Freyer D., Manz R., Ziegenhorn A., Weih M., Angstwurm K., Döcke W.D., Meisel A., Schumann R.R., Schönfelder G., Dirnagl U., Weber J.R. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J. Immunol. 1999, 163:4308-4314.
15. Grandgirard D., Gräumann R., Coulibaly B., Dangy J.P., Sie A., Junghanss T., Schudel H., Pluschke G., Leib S.L. The causative pathogen determines the inflammatory probile in cerebrospinal fluid and outcome in patients with bacterial meningitis. Mediat. Inflamm. 2013, 312476. 10.1155/2013/312476.
16. Gregersen R., Lambertsen K., Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 2000, 20:53-65.
17. Hoffmann O., Mahrhofer C., Rueter N., Freyer D., Bert B., Fink H., Weber J.R. Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect. Immun. 2007, 75:4289-4297.
18. Hoffmann O., Braun J.S., Becker D., Halle A., Freyer D., Dagand E., Lehnardt S., Weber J.R. TLR2 mediates neuroinflammation and neuronal damage. J. Immunol. 2007, 178:6476-6481.
19. Jensen M.B., Hegelund I.V., Lomholt N.D., Finsen B., Owens T. IFN gamma enhances microglial reactions to hippocampal axonal degeneration. J. Neurosci. 2000, 20:3612-3621.
20. Kiaei M., Kipiani K., Calingasan N.Y., Wille E., Chen J., Heissig B., Rafii S., Lorenzl S., Beal M.F. Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2007, 205:74-81.
21. Kim Y.S., Honkaniemi J., Sharp F.R., Täuber M.G. Expression of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta in the brain during experimental group B streptococcal meningitis. Mol. Brain Res. 2004, 128:95-102.
22. Koedel U., Klein M., Pfister H.W. New understandings on the pathophysiology of bacterial meningitis. Curr. Opin. Infect. Dis. 2010, 23:217-223.
23. Lacks S.A., Hotchkiss R.D. A study of the genetic material determining an enzyme in pneumococcus. Acta Biochem. Biophys. 1960, 39:508-517.
24. Leib S.L., Leppert D., Clements J., Täuber M.G. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect. Immun. 2000, 68:615-620.
25. Leppert D., Leib S.L., Grygar C., Miller K.M., Schaad U.B., Hollander G.A. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin. Infect. Dis. 2000, 31:80-84.
26. Lindsay K.W., Bone I., Fuller G. Acute bacterial meningitis. Neurology and Neurosurgery Illustrated 2011, 490-493. Elsevier, London & New York. 5th edition.
27. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., Kurt-Jones E., Paton J.C., Wessels M.R., Golenbock D.T. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1966-1971.
28. Mitchell T.J., Andrew P.W. Biological properties of pneumolysin. Microb. Drug Resist. 1997, 3:19-26.
29. Nadeau S., Rivest S. Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge. J. Neuropathol. Exp. Neurol. 1999, 58:61-77.
30. Nadeau S., Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J. Neurosci. 2000, 20:3456-3468.
31. Nau R., Soto A., Brück W. Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J. Neuropathol. Exp. Neurol. 1999, 58:265-274.
32. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., Pfister H.W. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 1998, 44:592-600.
33. Pfister H.W., Feiden W., Einhäupl K.M. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch. Neurol. 1993, 50:575-581.
34. Rennels M.L., Gregory T.F., Blaumanis O.R., Fujimoto K., Grady P.A. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 1985, 326:47-63.
35. Rennels M.L., Blaumanis O.R., Grady P.A. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv. Neurol. 1990, 52:431-439.
36. Rooney P., Bilbe G., Zak O., O'Reilly T. Dexamethasone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy. J. Med. Microbiol. 1995, 43:37-44.
37. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 2002, 22:10291-10301.
38. Sairanen T.R., Lindsberg P.J., Brenner M., Carpén O., Sirén A. Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J. Neurol. Sci. 2001, 186:87-99.
39. Tuomanen E., Tomasz A., Hengstler B., Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 1985, 151:535-540.
40. Tuomanen E.I., Saukkonen K., Sande S., Cioffe C., Wright S.D. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 1989, 170:959-969.
41. Weber J.R., Freyer D., Alexander C., Schröder N.W., Reiss A., Küster C., Pfeil D., Tuomanen E.I., Schumann R.R. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 2003, 19:269-279.